Roche agrees to buy a developer of a drug for people suffering from inflammatory bowel disease from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion, Textainer is being acquired for about $2.1 billion, and Microsoft and Alphabet lead a busy earnings week.
These Stocks Are Moving the Most Today: Roivant Sciences, Textainer, Okta, Microsoft, Alphabet
2023-10-23 16:50
Roche agrees to buy a developer of a drug for people suffering from inflammatory bowel disease from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion, Textainer is being acquired for about $2.1 billion, and Microsoft and Alphabet lead a busy earnings week.
You Might Like...
The newest mopping robot vacuums from iRobot, Shark, and Roborock are all on sale this week
Who is Sexyy Red? Kai Cenat chuckles as IShowSpeed shares fun interaction during livestream with rapper
Amouranth makes appearance as ring girl for Jake Paul vs Nate Diaz, fans say 'this is hot'
How to unblock and watch 9Now for free
Reddit CEO: We're Sticking With API Changes, Despite Subreddits Going Dark
When Does Warzone 2 Season 5 Reloaded go Live?
Ethan Klein calls xQc 'f**king idiot' and his 'take' on FaZe Rain and Grace Van Dien drama 'f**king dumb a**'
Google Pixel 8: Every single thing we know so far